[ad_1]
Shares of Becton Dickinson & Co. bounced back Wednesday toward their first gain in seven sessions after the Food and Drug Administration addressed supply issues surrounding blood-culture vials.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...